期刊文献+

降钙素原在新生儿感染疾病中的应用 被引量:3

Clinical application of Procalcitonin in neonatal infection
下载PDF
导出
摘要 目的评价降钙素原(PCT)在诊断新生儿感染性疾病中的临床应用。方法收集2012年1—12月被我院NICU收治的新生儿感染性疾病138例,并根据感染严重度评分(SSS)将其分为重症感染组55例、一般感染组83例,同时选同期非感染新生儿病例50例,应用半定量免疫色谱法分别测定三组的血清PCT水平,并与血清C-反应蛋白(CRP)的诊断结果相比较。结果重症感染组的PCT均明显高于另两组(P<0.05或P<0.01),一般感染组的PCT阳性率较非感染组间高(P均<0.05);PCT对新生儿重症感染诊断的敏感性为87.3%明显高于CRP的56.4%(P<0.05),二者特异度差异并无显著性。结论 PCT可作为新生儿感染疾病的一项灵敏检测指标,尤其适用于的重症感染新生儿的诊断和治疗,较CRP更具临床应用价值。 Objective To evaluate procalcitonin(PCT) applied in the diagnosis of neonatal infection.Methods The selection of 138 cases of neonatal infectious diseases whcih were collected from January 2012 to december 2012 were divided into 55 cases of severe infection group and 83 cases of general infection group two groups according to the infection severity score,electing 50 cases of non-infected newborns as the control group.3 groups of the level of serum PCT were tested by Semiquantitative immune chromatography,compared to the level of serum C-reactive protein(CRP).Results The level of serum PCT in severe infection group was significantly higher than the other two groups's(P0.05 or P0.01),the level of serum PCT in the general infection group was higher than the control group's(P0.05);The sensitivity of PCT and CRP for diagnosis of neonatal infection was 87.3% and 56.4% respectively,there was no significant difference(P0.05).Conclusions PCT is more sensitive than CRP and neonatal infection can be diagnosed and treated much earlier,more sensitively by using the detection of PCT.
作者 刘平
出处 《齐齐哈尔医学院学报》 2013年第9期1267-1268,共2页 Journal of Qiqihar Medical University
关键词 降钙素原 新生儿 感染性疾病 应用价值 Procalcitonin Neonatal Infectious diseases Application value
  • 相关文献

参考文献7

二级参考文献47

共引文献138

同被引文献36

  • 1周颖杰,李光辉.成人及儿童复杂性腹腔内感染的诊断与处理:美国外科感染学会及美国感染病学会指南[J].中国感染与化疗杂志,2010,10(4):241-247. 被引量:238
  • 2Indino P, Lemarchand P, Bady P, et al. Prospective study on procalci- tonin and other systemic infection markers in patients with leukocytosis [J]. Int J Infect Dis,2008,12(3) :319-324.
  • 3Becker KL, Snider R, Nylen ES. Procalcitonin in sepsis and systemic inflammation:a harmful biomarker and a therapeutic target [ J ]. Br J Pharmaeo1,2010,159 ( 2 ) :253-264.
  • 4Assicot M, Gendrel D, Carsin H,et al.High serum procal- citonin concentration in patients with sepsis and infection [J].Lancet, 1993,341 (8844) : 515-518.
  • 5Gendrel D, Bohuon C.Procalcitonin as a marker of bacteri- al infection[J].Pediatr Infect Dis J, 2009,19 (3) : 679.
  • 6Oberhoffer M,Stonauns L,Russwurm S,et a/.Procaleitonin expression in human peripheral blood mononuclear cells and itsmodulation bulipopolysaceharides and sepsisrelated cytokines in vitro[J].Lab Clin Med,2009,134( 1 ) :49-52.
  • 7Bustos BR,Araneda CH.Procalcitonin for the diagnosis of late onset sepsis in newborns of very low birth weight[J].Rev Chilena Infectol, 2012,29 (5) : 511-516.
  • 8Karzai W, Oberhoffer M, Meier-hellmann A,et al.Proca- lcitonin--a new indicator of the systemic response to severe infections[J].Infection, 1997,25(6) : 329-334.
  • 9Chiesa C,Panero A,Rossi N,et al.Reliability of procalcitonin concentrations for the diagnosis of sepsis in critically III neonates[J].Clin Infect Dis, 1998,26(3 ): 664-672.
  • 10Liu SF,Yuan GP,Yang J,et al.Procalcitonin as a predictor of trauma severity and post-traumatic sepsis in children[J]. Sichuan Da Xue Xue Bao Yi Xue Ban,2012,43(5):706- 710.

引证文献3

二级引证文献54

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部